SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-058582
Filing Date
2009-11-06
Accepted
2009-11-05 17:58:52
Documents
9
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c91654e10vq.htm 10-Q 327030
2 EXHIBIT 10.1 c91654exv10w1.htm EX-10.1 4696
3 EXHIBIT 10.2 c91654exv10w2.htm EX-10.2 4472
4 EXHIBIT 31.1 c91654exv31w1.htm EX-31.1 8738
5 EXHIBIT 31.2 c91654exv31w2.htm EX-31.2 8666
6 EXHIBIT 32.1 c91654exv32w1.htm EX-32.1 3141
7 EXHIBIT 32.2 c91654exv32w2.htm EX-32.2 3116
8 GRAPHIC c91654c9165401.gif GRAPHIC 92795
9 GRAPHIC c91654c9165402.gif GRAPHIC 191554
  Complete submission text file 0000950123-09-058582.txt   753346
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 091162290
SIC: 2836 Biological Products, (No Diagnostic Substances)